Clinical trial

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

NCT05089942

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-12-01

PhasePHASE4

Study timeline

Study start (estimated)2021-12-01Date precision: month

Registry last updated2021-11-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

type1diabetesunresolved

Type2 Diabetesunresolved

Interventions

Recombinant Human Insulin Patch ZJSRM2021DRUG

PlaceboDRUG

Sponsors & collaborators

Zhejiang Provincial People's Hospitallead sponsor

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05089942 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.